Abstract: Introduction -Our previous study cleared that both immunization with Egyptian Schistosoma mansoni schistosomula and therapy with praziquantel were able to induce significant levels of protection against re-infection as compared with immunization or treatment only. Aim -The current study aimed to evaluate the immunostimulatory activity of schistosomula in naïve mice post injection with schistosomula either alone or with praziquantel to answer the question: can schistosomula be used as immunoadjuvant? Material and Methods -Ten naïve mice were administered 3 doses of phosphate buffered saline. Ten mice injected with 500 schistosomula at day 0 and at 14 th day. Ten mice were administered praziquantel (PZQ) (250 mg/kg body weight).Ten mice injected with schistosomula at day 0 and at 14 th day and received PZQ. 
Abstract: Introduction -Our previous study cleared that both immunization with Egyptian Schistosoma mansoni schistosomula and therapy with praziquantel were able to induce significant levels of protection against re-infection as compared with immunization or treatment only. Aim -The current study aimed to evaluate the immunostimulatory activity of schistosomula in naïve mice post injection with schistosomula either alone or with praziquantel to answer the question: can schistosomula be used as immunoadjuvant? Material and Methods -Ten naïve mice were administered 3 doses of phosphate buffered saline. Ten mice injected with 500 schistosomula at day 0 and at 14 th day. Ten mice were administered praziquantel (PZQ) (250 mg/kg body weight).Ten mice injected with schistosomula at day 0 and at 14 th day and received PZQ. The levels of IgM and IgG against soluble egg antigen (SEA) and soluble worm antigen preparation (SWAP) were detected by ELISA. Immunophenotyping of mesenteric lymph nodes (MLN) lymphocytes and thymocytes were carried out. Results -IgM and IgG levels were significantly elevated in sera from mice injected with schistosomula alone or with PZQ or PZQ only. Introduction Schistosomiasis, a debilitating disease caused by trematode blood flukes of the genus Schistosoma, is recognized as the most important human helminth infection in terms of morbidity and mortality. According to the world health organization, schistosomiasis affects about 250 million people worldwide [1] .
Schistosoma mansoni infection occurs after direct contact with freshwater harboring free swimming cercariae which penetrate the skin of humans and enter capillaries and lymphatic vessels en route to the lungs. After several days, the schistosomula migrate to the portal venous system, where they mature and unite. Then migrate to superior mesenteric veins. Eggs are deposited in the vein lumen and pass into the host tissues, and then many pass through the intestinal mucosa and are shed in the feces [2] .
Despite the existence of praziquantel (PZQ), schistosomiasis is spreading into new areas, PZQ chemotherapy does have limitations. In particular, mass treatment does not prevent reinfection. Furthermore, the prospect of relying on a single drug is of concern and the potential for drug resistance, particularly in areas of high transmission must be considered [3, 4] . Consequently, vaccine strategies represent an essential component for the future control of schistosomiasis as an adjunct to chemotherapy. These vaccines function mainly through inducing specific antibody responses or activating CD4 + -T cells against schistosomula or adult worms [5, 6] . However, the role of CD8 + -T cell responses has been considered as a potential aspect in the development of vaccine against schistosomiasis [7] . Evidence indicated that an Ag specific CD8 + -T cell response was induced in schistosome infected mice [8, 9] .
Vaccines efficacy is directly related to adjuvant effect that prolong the immunological memory of vaccines and broaden the antibody repertoire. Adjuvants can drive the immune system to a Th1, Th2 or mixed Th1/Th2 response [10] .
Lung schistosomula are more efficient stimulators of lymphocyte proliferation and secretion of Th1 cytokines than those from cercariae and skin-stage larvae [11, 12] . Immunization of mice with schistosomula tegument (Smteg) plus Freunds adjuvant, characterized by IFN-γ, IgG1 and IgG2c production, induced damage in parasite tegument [13, 14] . The objective of the present study is to determine the immunostimulatory activity of Egyptian S. mansoni schistosomula on cellular and humoral
Experimental groups
Group1: A total of 40 female Swiss albino mice were divided into ten naïve mice were orally administered 3 doses of phosphate buffered saline and maintained at the same condition to be used as normal group.
Group 2: Ten mice were subcutaneously injected with 500 schistosomula at day 0 and received the second dose at 14 th day. Post 1 st and 2 nd injections, blood samples were collected from each individual mouse via optical vein and sera were separated.
Group 3: Ten mice were orally administered 3 doses of PZQ (250 mg/kg body weight). After each dose of PZQ, individual serum was separated.
Group 4: Ten mice were injected with schistosomula at day 0 and received the second dose at 14 th day followed by administration of 3 doses of PZQ at the same time of the Group 2. After the last dose of PZQ individual blood samples were collected and sera were separated and frozen at -80°C till being used.
Determination of antibody titers in the mice sera by enzyme linked immune-sorbent assay (ELISA)
The levels of IgM and IgG in sera from animals were detected by ELISA according to Maghraby & Bahgat [16] . Plates were coated with (50 μl/well) of soluble worm antigen preparation (SWAP: 50 μg/ml) and soluble egg antigen (SEA: 50 μg/ml). Antigen free sites were blocked against non-specific binding using (100 μl/well) of phosphate buffered saline containing 0.05% Tween20-5% fetal calf serum (PBST-FCS) and incubated at 37ºC for 1 h. After thee washes with phosphate buffered saline containing 0.05% Tween-20 (PBS-T20), diluted sera (1:50) in PBST-FCS were applied (50 μl/well) and plates were incubated at 37ºC for 2 h. For total IgG detection, peroxidase conjugated anti-mouse IgG (H+L) was added (50 μl/well) at 1:500 dilution in PBST-FCS and plates were incubated at 37ºC for 1 h. For IgM Goat-anti mouse IgM (μ) conjugated with Horseradish peroxidase was added (50 μl/well) at 1:500 dilutions in PBST-FCS and plates were incubated at 37ºC for 1 h. For color development, a volume of (100 μl/well) of Orthophenylenediamine (OPD) (Sigma, St. Louis, Mo, USA) diluted in substrate buffer and left for 10 min at room temperature till color development. The enzymatic reaction was stopped using 50 μl of 2 M HCl and the changes in optical density (OD) were recorded at λ max 490 nm using a multi-well plate reader (139 Tecan; Sunrise,GmbH, Grödig, Austria). 
Immunophenotyping of different lymphocytes populations
Mesenteric lymph nodes (MLNs) and thymus were excised, gently teased in petri dishes containing PBST-FCS using glass slides. Cells from individual mouse were washed three times with PBST-FCS followed by centrifugation at 1500 g at 4°C for 10 min. CD4 + T-and Blymphocytes, the green fluorescence stained lymphocytes were counted in a minimum of 100-200 viable cells using a fluorescence microscope (Zeiss Axioskop, Jena, Germany) according to Maghraby [17] .
Statistical analysis
All obtained data were analyzed by the Students't-test using the Graph Pad InStat Software. The data were expressed as mean with standard deviation -Mean±SD. Data were considered significant when P-values were <0.05. The non significanct data were represented as: N.S. dose (0.47±0.14; fold=1.16), the differences among the 3 doses were not significant (P>0.05) ( Table 2 ). The IgG level in sera from schistosomula-PZQ administered mice showed a significant increase (P<0.001) as compared with normal level. However, the IgG level in sera from this group showed non-significant increase (P>0.05) when compared with IgG level in sera from PZQ administered mice after the 1 st (0.46±0.08; fold= 1.3), 2 nd (0.47±0.14; fold=1.27) and 3 rd (0.54±0.03; fold= 1.09) doses of PZQ. It was also observed that the IgG level in sera from schistosomula-PZQ administered mice showed nonsignificant changes (P>0.05) as compared with schistosomula injected mice ( Table 2) . dose (0.52±0.14; fold=1.13), the differences among the 3 doses were not significant (P>0.05) ( Table 3 ). The IgM level in sera from schistosomula-PZQ administered mice showed significant increase (P<0.001) as compared with normal level. The IgM level in sera from this group showed significant increase (P<0.01) as compared with that from mice administered the 1 st dose of PZQ (0.39±0.09). However, it showed non-significant increase (P>0.05) when compared with IgM level in sera from PZQ administered mice after the 2 nd (0.52±0.14; fold= 1.22) and the 3 rd (0.58±0.04; fold=1.08) doses of PZQ. It was also observed that the IgM level in sera from schistosomula-PZQ administered mice showed non-significant changes (P>0.05) as compared with schistosomula injected mice (Table 3) . Table 4) .
Results
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The IgG level in sera from schistosomula-PZQ administered mice showed significant increase (P<0.001) as compared with normal level. There were non-significant changes (P>0.05) in IgG levels in sera among schistosomula-PZQ administered mice (0.45±0.04) and either the schistosomula injected mice or the PZQ administered mice (Table 4) .
Mean percentage of thymocytes from schistosomula or/and PZQ administered mice
Post 1 st and 2 nd injections with schistosomula, the mean percentage (%) of CD4 + or CD8 + thymocytes showed nonsignificant changes (P>0.05) as compared with normal thymocytes %. Although 2 nd schistosomula injected mice showed higher mean % of CD4 + or CD8 + thymocytes (43.2±1.3, 35.0±1.4 respectively) than 1 st schistosomula injected mice 42.0±2.0 (fold=1.03), 33.1±2.1 (fold=1.06) respectively, these increments were not considered significant (P>0.05) ( Table 5) .
PZQ administered mice showed non-significant change (P>0.05) in the mean % of CD4 + or CD8 + thymocytes as compared with naïve thymocytes mean % ( 
Discussion
Our previous studies demonstrated that immunization with schistosomula associated with therapy were able to induce partial reduction in worm burden (68.5%) against Schistosoma mansoni reinfection and modulate the immunocellular response [18] . We observed that injection with schistosomula stimulated the humoral immune response in naïve mice whereas, IgM and IgG levels were elevated in mice post injection with schistosomula alone or with PZQ or PZQ. De Melo et al. [19] detected significant levels of antischistosomula tegument (Smteg) IgG antibodies in the sera of mice injected with Smteg compared to control group. This is also is in accordance with the results of de Melo et al. [20] who transferred sera from mice immunized with Smteg or Smp-80 to a naïve recipient and that was able to induce partial protection against challenge infection. Our data allowed us to speculate that, PZQ administration enhanced the humoral response in naïve mice. The IgM and IgG levels elevation observed in PZQ administered mice may reflect the sensitization of more lymphocytes by specific PZQ action, which is in accordance with the low toxicity and good tolerance of the drug in animals and healthy human volunteers [21] . Cellular immune responses are also important in parasite elimination. Recent studies showed that protective immunity associated Th2 profile was observed in out-bred mice immunized with glyceraldehyde3-phosphate dehydrogenase (SG3PDH) and peroxiredoxin (TPX) [22] . Blocking IL-10 with neutralizing antibodies enables protection against challenge infection in mice previously infected with S. mansoni and treated with praziquantel [23] . In S. japonicum infection, blocking IL-17 with neutralizing antibodies enhances antibody production and protection in infected mice [24] .
Although CD8 + T cells are classically related to immune responses against intracellular pathogens, its role in schistosome elimination has been recently described. Immunization of mice with the S. japonicum 22.6/26GST coupled to sepharose 4B bead induced a significant reduction in parasite burden that was associated with an increase in the number of activated CD8 + T cells. These activated CD8 + T cells were able to promote death of parasite carrying host the major histocompatibility 1 (MHCI) molecules in its surface [9] . S. japonicum calreticulin is one of the immunostimulatory molecules released from radiation-attenuated schistosomula cells, might play a crucial role in conferring a Th1-polarized immune response induced by radiation-attenuated cercariae/schistosomula in mice [25] .
Conclusion
In the current our study, the schistosomula may be considered as immunostimulatory adjuvant by enhancing the humoral immunostimulating response of IgM and IgG levels. Furthermore, schistosomula stimulated the cellular immune response of thymus and mesenteric lymph nodes organs whereas the ratio of thymocytes and MLN-CD4 + /CD8 + T-lymphocytes >1. Also, and MLN-B cells were evoked. Of particular interest to this study, the schistosomula-PZQ administration was able also to stimulate the humoral and cellular immune responses also, the ratio of MLN-CD4 + /CD8 + T-lymphocytes >1 and the mean percentage of MLN Blymphocytes was stimulated.
